GLP-1 and Anesthesia: The Gastric Ultrasound Protocol That Could Save Your Life

GLP-1 and Anesthesia: The Gastric Ultrasound Protocol That Could Save Your Life

Most people on Ozempic or Mounjaro have no idea their medication could make anesthesia more dangerous. Not because these drugs are bad — but because they dramatically slow down how fast your stomach empties. And when food or liquid stays in your stomach longer than expected, going under general anesthesia carries a real risk of aspiration.

Here is the good news: there is a specific pre-anesthesia ultrasound protocol designed exactly for this situation. And there are clear steps you can take — starting weeks before your surgery — to reduce your risk significantly.

Important: I'm not a doctor. Everything I share here is based on published research and clinical guidance. Talk to your anesthesiologist and prescribing physician before making any changes ahead of surgery.

---

The Bottom Line

The Bottom Line

• GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) slow gastric emptying — meaning food and liquid sit in your stomach longer than normal, even after standard fasting.
• Going into surgery with a "full stomach" raises the risk of aspiration (stomach contents entering the lungs during anesthesia) — a serious, potentially fatal complication.
• Many anesthesiologists now use a bedside gastric ultrasound to check whether your stomach is actually empty before proceeding — this is a fast, non-invasive scan done in the pre-op area.
• Actionable step: Tell your surgeon and anesthesiologist you are on a GLP-1 drug, how long you have been on it, and your current dose — ideally at your pre-surgical consult, not the morning of surgery.
• Current guidance from the American Society of Anesthesiologists recommends considering pausing weekly GLP-1 injections for one week before elective surgery. Talk to your prescribing doctor before stopping any medication.

---

Why GLP-1 Drugs Change the Anesthesia Equation

GLP-1 receptor agonists work — in part — by slowing down gastric motility. That is a technical way of saying they pump the brakes on how fast your stomach moves food into your small intestine.

For weight management, this is a feature. Feeling full longer means eating less. But in the operating room, it creates a specific problem.

Standard pre-anesthesia fasting rules — nothing to eat for 6-8 hours, nothing to drink for 2 hours — were built around a normal, healthy stomach. A normal stomach empties a meal in roughly 4-5 hours. But research shows GLP-1 drugs can extend that timeline significantly, with some studies documenting solid food still present in the stomach after fasting periods that would normally guarantee an empty stomach.

A 2024 study published in Anesthesia & Analgesia specifically examined gastric content in GLP-1 users before anesthesia using ultrasound — and found higher-than-expected rates of residual gastric content even in patients who had followed standard fasting instructions.

That matters because aspiration — when stomach contents enter the airway during intubation — is one of the most serious complications in anesthesia. It can cause aspiration pneumonia, lung injury, or worse.

---

What Is Gastric Ultrasound and How Does It Work?

Think of it like a pregnancy ultrasound, but for your stomach.

A trained anesthesiologist or sonographer places a small handheld probe on your upper abdomen. In under five minutes, they can see whether your stomach is empty, contains clear liquid, or has solid or thick content inside it.

The technique is called point-of-care gastric ultrasound (POCUS), and it has become increasingly standard in anesthesia departments that manage patients on GLP-1 drugs.

What They Are Looking For

There are three possible findings:

1. Empty stomach — flat, no visible content. Proceed with standard anesthesia protocol.
2. Clear fluid only — thin liquid present. Volume matters. Less than 1.5 mL/kg body weight is generally considered acceptable. Above that, the team may delay or modify the plan.
3. Solid or thick content — food particles or semi-solid material visible. This is the high-risk finding. The anesthesia plan will change — more aggressive airway management (like rapid sequence induction), or the surgery may be postponed.

The scan is done lying on your back and then on your right side. Rotating right helps liquid pool toward the antrum (the lower part of the stomach), making it easier to visualize and measure.

---

The Step-by-Step Protocol: What Should Happen Before Your Surgery

This is what the research and current anesthesia guidance supports. Use this as a checklist — for yourself and for the conversations you need to have with your care team.

Step 1: Disclose Your GLP-1 Use at Every Pre-Surgical Appointment

Do not assume your surgical team knows you are on semaglutide or tirzepatide. These drugs are prescribed by endocrinologists, primary care doctors, and weight management clinics — not always the same team doing your surgery.

Tell them:

• The name of the drug (semaglutide, tirzepatide, liraglutide, etc.)
• Your current dose
• How frequently you inject (weekly vs. daily)
• When you took your last dose

This information should be in your anesthesia pre-assessment — not just your medication list buried in your chart.

Step 2: Have the Conversation About Pausing Your Medication

The American Society of Anesthesiologists (ASA) issued guidance in 2023 recommending that patients on weekly GLP-1 injections consider holding the dose for one week before elective procedures under general anesthesia. For daily GLP-1 medications, the suggested hold is the day before the procedure.

This guidance is being updated as new data comes in — so what your doctor tells you in 2026 may differ. The point is: this needs to be a deliberate, documented conversation with both your prescribing doctor and your anesthesiologist. Do not make the call on your own.

Do not stop any medication without talking to your doctor first. For people using GLP-1 drugs for type 2 diabetes management, stopping abruptly can affect blood sugar control.

Step 3: Follow Extended Fasting Instructions If Your Team Recommends Them

Some anesthesia teams managing GLP-1 patients are extending standard fasting times — particularly for solids. The usual rule is nothing solid for 8 hours. For GLP-1 users, some protocols now recommend no solids for up to 12 hours, with clear liquids stopping 2-4 hours before anesthesia.

Your team will specify. Follow their instructions exactly.

Step 4: Expect (and Ask For) a Gastric Ultrasound Before Induction

If your hospital or surgery center is following current best practice for GLP-1 patients, they should perform a bedside gastric ultrasound in the pre-op area before you go under.

If they do not mention it — ask. You are not being difficult. You are being an informed patient. The scan takes less than five minutes and the information it provides can meaningfully change how your anesthesiologist manages your airway.

Step 5: Understand What Happens If the Scan Shows Residual Content

If the scan finds solid material in your stomach, your care team has a few options:

• Delay the surgery to allow more time for gastric emptying (if it is elective)
• Proceed with modified airway technique — specifically rapid sequence induction (RSI), where drugs are given quickly and a breathing tube placed faster to minimize the window of aspiration risk
• Consult with the surgical team on whether the procedure is truly urgent enough to accept the elevated risk

If your surgery is elective and the scan shows solid content, postponing is generally the safest call.

---

Common Mistakes People on GLP-1s Make Before Surgery

These are the situations that put patients at unnecessary risk. Avoid all of them.

Mistake 1: Not telling your anesthesiologist about your GLP-1 drug. People sometimes omit it because they do not consider it a "real" medication or think it only affects weight. Your full medication list matters. Every drug on it matters.

Mistake 2: Assuming standard fasting rules are enough. They probably are not — at least not without verification. Standard fasting was calibrated for a normally functioning stomach. GLP-1 drugs change that baseline.

Mistake 3: Stopping your GLP-1 without talking to your prescriber. The ASA guidance is a recommendation. Your individual situation — blood sugar management, obesity-related surgical risk, drug half-life — may change what the right call is for you specifically.

Mistake 4: Not asking about gastric ultrasound availability. Not every facility has the equipment or trained staff. If yours does not, ask what alternative precautions they are taking for GLP-1 patients. This is a fair question.

Mistake 5: Thinking this only applies to major surgery. Gastric aspiration risk applies to any procedure requiring general anesthesia or deep sedation — including endoscopy, colonoscopy, and dental procedures under sedation. The same principles apply.

---

What the Research Actually Shows

A key study available on PubMed (PMID 41032460) focused specifically on using gastric ultrasound to assess stomach content in GLP-1 users before anesthesia. The findings are worth knowing.

Patients on GLP-1 receptor agonists had significantly higher rates of residual gastric content detected on ultrasound compared to patients not on these drugs — even after following standard fasting protocols.

This is not a theoretical risk. Anesthesiologists are seeing it in real pre-op assessments.

The study supports the shift toward routine gastric ultrasound for this patient population, and toward modified fasting and medication hold protocols as standard care.

The research field is moving fast here. As more people use GLP-1 drugs — tens of millions are now on semaglutide or tirzepatide in the US alone — the anesthesia community is rapidly building out evidence-based protocols to match.

---

A Note on Drug-Specific Differences

Not all GLP-1 drugs affect gastric emptying equally.

Semaglutide (the active ingredient in Ozempic and Wegovy) has a long half-life — roughly one week. That means even if you took your last dose six days ago, it is still active in your system.

Liraglutide (Victoza, Saxenda) has a shorter half-life — about 13 hours — so daily dosing, and a shorter hold period before surgery, reflects this difference.

Tirzepatide (Mounjaro, Zepbound) acts on both GLP-1 and GIP receptors. Its half-life is approximately five days. Its effect on gastric motility may differ from pure GLP-1 agonists, though research is still catching up.

Your anesthesiologist should know which drug you are on and factor the half-life into their assessment. This is one more reason full disclosure matters.

---

FAQ

Do I have to stop Ozempic before surgery?

Current ASA guidance suggests considering a one-week hold for weekly GLP-1 injections before elective surgery. But this is not a blanket rule — it depends on why you are taking it, your surgery type, and your individual medical situation. Your prescribing doctor and anesthesiologist need to make this call together. Never stop on your own.

What is the aspiration risk with GLP-1 drugs specifically?

Aspiration happens when stomach contents enter the lungs during anesthesia. GLP-1 drugs slow gastric emptying, which means solid or liquid content may remain in the stomach longer than standard fasting rules account for. This increases aspiration risk compared to patients not on these drugs — but the absolute risk is still low when properly managed.

How accurate is gastric ultrasound for checking stomach contents?

Research supports gastric ultrasound as a reliable bedside tool for qualitatively assessing gastric content (empty vs. liquid vs. solid) and estimating volume. It is not perfect — it requires trained operators and good visualization — but it provides information that no other pre-op tool offers in real time.

What if my hospital does not offer gastric ultrasound?

Ask what their protocol is for GLP-1 patients. Alternatives include extended fasting periods, modified anesthesia technique (rapid sequence induction), or postponing elective procedures. The absence of ultrasound does not mean you cannot have surgery safely — it means the team relies more heavily on precautions rather than real-time verification.

Can I have a colonoscopy or endoscopy if I am on semaglutide?

Yes, but the same gastric emptying concerns apply. Gastroenterology teams are increasingly aware of this issue. Disclose your GLP-1 use to the procedural team and ask about any modified prep instructions. Some centers are extending clear liquid-only prep periods for GLP-1 patients.

---

The Bottom Line: What to Do Starting Today

If you are on any GLP-1 drug and have surgery or a sedation procedure on the horizon — near or far — here is your action plan.

First, put your GLP-1 drug prominently on your medication list everywhere: your chart, your pre-op intake form, your verbal disclosure to the nurse, your conversation with the anesthesiologist.

Second, ask at your pre-surgical consult whether your team has a protocol for GLP-1 patients and whether gastric ultrasound is part of it.

Third, have an explicit conversation with both your prescribing doctor and your anesthesiologist about whether to hold your dose before surgery and for how long.

Fourth, follow any extended fasting instructions your team gives you. Do not improvise.

This is one of those situations where being a little pushy about your own care is the right call. The research is clear that standard protocols were not designed with GLP-1 patients in mind. The good news is the anesthesia community is catching up — but you have to give them the information they need to protect you.

---

Medical Disclaimer: The information on this website is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol, medication, or supplement regimen — and before making any changes to your medications ahead of a surgical or procedural procedure. Individual results vary. The author shares personal experience and published research — not medical recommendations.

---

Sources

1. Assessment of Gastric Content Using Gastric Ultrasound in Patients on GLP-1 Receptor Agonists Before Anesthesia — PubMed, 2024
2. GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials — PubMed, 2026
3. New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication — Nutrients, 2026
4. American Society of Anesthesiologists Guidance on GLP-1 Receptor Agonists and Perioperative Care — ASA, 2023
5. The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis — Nephrology, Dialysis, Transplantation, 2026